

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.83860866 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.83860866 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.64666696 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.93937137 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.53524170 |
| 6 | regulation of ARF protein signal transduction (GO:0032012) | 4.32331575 |
| 7 | sodium ion export (GO:0071436) | 4.20016786 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.09844164 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.06283431 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.06283431 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65577055 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.58540486 |
| 13 | cellular response to zinc ion (GO:0071294) | 3.56196463 |
| 14 | locomotory exploration behavior (GO:0035641) | 3.52876173 |
| 15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49447452 |
| 16 | response to muramyl dipeptide (GO:0032495) | 3.47739850 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45433877 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.38697258 |
| 19 | protein localization to endosome (GO:0036010) | 3.36543537 |
| 20 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.35171753 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.30536804 |
| 22 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.29238192 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.25874858 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 3.17703130 |
| 25 | response to peptidoglycan (GO:0032494) | 3.17348381 |
| 26 | nuclear pore complex assembly (GO:0051292) | 3.16241862 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10881546 |
| 28 | negative T cell selection (GO:0043383) | 3.10869492 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09994509 |
| 30 | regulation of histone H3-K27 methylation (GO:0061085) | 3.09611582 |
| 31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08003465 |
| 32 | natural killer cell differentiation (GO:0001779) | 3.04712380 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02706232 |
| 34 | cellular response to virus (GO:0098586) | 3.01994611 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 2.98444751 |
| 36 | germinal center formation (GO:0002467) | 2.97501988 |
| 37 | detection of other organism (GO:0098543) | 2.96264017 |
| 38 | response to type I interferon (GO:0034340) | 2.94519829 |
| 39 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.94344703 |
| 40 | modulation by symbiont of host cellular process (GO:0044068) | 2.93283882 |
| 41 | positive regulation of histone deacetylation (GO:0031065) | 2.92926171 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 2.92654295 |
| 43 | regulation of defense response to virus by virus (GO:0050690) | 2.92406261 |
| 44 | detection of bacterium (GO:0016045) | 2.91843033 |
| 45 | type I interferon signaling pathway (GO:0060337) | 2.90793140 |
| 46 | cellular response to type I interferon (GO:0071357) | 2.90793140 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.90478767 |
| 48 | histone H3-K36 demethylation (GO:0070544) | 2.90132162 |
| 49 | mannose metabolic process (GO:0006013) | 2.90002518 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89609766 |
| 51 | cellular response to interferon-alpha (GO:0035457) | 2.89397493 |
| 52 | positive thymic T cell selection (GO:0045059) | 2.86927263 |
| 53 | response to laminar fluid shear stress (GO:0034616) | 2.86448607 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85927028 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84130036 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 2.83873506 |
| 57 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.83522064 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 2.81967268 |
| 59 | peptidyl-lysine dimethylation (GO:0018027) | 2.81199962 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80566639 |
| 61 | regulation of ARF GTPase activity (GO:0032312) | 2.80211287 |
| 62 | activation of protein kinase A activity (GO:0034199) | 2.79297764 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 2.78734924 |
| 64 | oxaloacetate metabolic process (GO:0006107) | 2.78068023 |
| 65 | alanine transport (GO:0032328) | 2.77474526 |
| 66 | pre-miRNA processing (GO:0031054) | 2.76332597 |
| 67 | cell communication by electrical coupling (GO:0010644) | 2.74700566 |
| 68 | regulation of translational termination (GO:0006449) | 2.74657034 |
| 69 | proline transport (GO:0015824) | 2.73845537 |
| 70 | regulation of necroptotic process (GO:0060544) | 2.73104670 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.72874323 |
| 72 | response to host defenses (GO:0052200) | 2.72860706 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72860706 |
| 74 | response to host (GO:0075136) | 2.72860706 |
| 75 | regulation of RNA export from nucleus (GO:0046831) | 2.72432394 |
| 76 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.72423191 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.71785569 |
| 78 | response to interferon-alpha (GO:0035455) | 2.71719024 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69474852 |
| 80 | pinocytosis (GO:0006907) | 2.68055294 |
| 81 | thymic T cell selection (GO:0045061) | 2.65826819 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.65069692 |
| 83 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.65035294 |
| 84 | T cell selection (GO:0045058) | 2.64747313 |
| 85 | signal complex assembly (GO:0007172) | 2.63666349 |
| 86 | Golgi transport vesicle coating (GO:0048200) | 2.61972246 |
| 87 | COPI coating of Golgi vesicle (GO:0048205) | 2.61972246 |
| 88 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60848868 |
| 89 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60541108 |
| 90 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59849197 |
| 91 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.56913572 |
| 92 | positive T cell selection (GO:0043368) | 2.56868319 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55741096 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.55632827 |
| 95 | glutamate secretion (GO:0014047) | 2.53132981 |
| 96 | focal adhesion assembly (GO:0048041) | 2.52043326 |
| 97 | cell-substrate adherens junction assembly (GO:0007045) | 2.52043326 |
| 98 | detection of external biotic stimulus (GO:0098581) | 2.51818375 |
| 99 | response to host immune response (GO:0052572) | 2.51012357 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51012357 |
| 101 | regulation of B cell differentiation (GO:0045577) | 2.50822043 |
| 102 | substrate-dependent cell migration (GO:0006929) | 2.49435540 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 2.49263699 |
| 104 | modulation by virus of host process (GO:0019054) | 2.49240711 |
| 105 | response to interleukin-15 (GO:0070672) | 2.48803071 |
| 106 | myeloid dendritic cell differentiation (GO:0043011) | 2.48368457 |
| 107 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.48240304 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47795945 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47795945 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 2.47795945 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47795945 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 2.47795945 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47795945 |
| 114 | negative regulation of viral release from host cell (GO:1902187) | 2.47534265 |
| 115 | negative regulation of necroptotic process (GO:0060546) | 2.47050352 |
| 116 | neurotransmitter secretion (GO:0007269) | 2.46803188 |
| 117 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46166595 |
| 118 | mitotic chromosome condensation (GO:0007076) | 2.45107331 |
| 119 | detection of molecule of bacterial origin (GO:0032490) | 2.45070544 |
| 120 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.43790993 |
| 121 | pore complex assembly (GO:0046931) | 2.42873498 |
| 122 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.42411094 |
| 123 | RNA stabilization (GO:0043489) | 2.42007725 |
| 124 | mRNA stabilization (GO:0048255) | 2.42007725 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.41807947 |
| 126 | nuclear pore organization (GO:0006999) | 2.40375005 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.40099778 |
| 128 | cellular sodium ion homeostasis (GO:0006883) | 2.40096862 |
| 129 | adherens junction assembly (GO:0034333) | 2.39748407 |
| 130 | leukocyte aggregation (GO:0070486) | 2.39472752 |
| 131 | stress fiber assembly (GO:0043149) | 2.39316983 |
| 132 | immunoglobulin mediated immune response (GO:0016064) | 2.38934357 |
| 133 | potassium ion import (GO:0010107) | 2.37896130 |
| 134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37545306 |
| 135 | activation of MAPKKK activity (GO:0000185) | 2.36934825 |
| 136 | cerebellar Purkinje cell layer development (GO:0021680) | 2.35549363 |
| 137 | histone H3-K9 demethylation (GO:0033169) | 2.33932857 |
| 138 | histone lysine demethylation (GO:0070076) | 2.33000017 |
| 139 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32536110 |
| 140 | cellular response to interferon-gamma (GO:0071346) | 2.31112348 |
| 141 | regulation of cellular amide metabolic process (GO:0034248) | 2.30731714 |
| 142 | regulation of synapse structural plasticity (GO:0051823) | 2.29854770 |
| 143 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.29749213 |
| 144 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.29733840 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.28937462 |
| 146 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.28351976 |
| 147 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27358027 |
| 148 | macroautophagy (GO:0016236) | 2.26522888 |
| 149 | regulation of response to interferon-gamma (GO:0060330) | 2.26022414 |
| 150 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.25782998 |
| 151 | positive regulation of vesicle fusion (GO:0031340) | 2.25253959 |
| 152 | negative regulation of cell size (GO:0045792) | 2.24041580 |
| 153 | T cell migration (GO:0072678) | 2.24039324 |
| 154 | growth hormone receptor signaling pathway (GO:0060396) | 2.22548373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.57931155 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.02317395 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.49458887 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35233895 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.31009650 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82570731 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67053570 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50280110 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.43255164 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38930383 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36847565 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34012522 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31895151 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19694869 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.17203550 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.16269188 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15347502 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.14776545 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.13788981 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08158889 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07253050 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00669450 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99861499 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97360856 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92591061 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89622243 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89175927 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85582916 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82618062 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80306289 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80287958 |
| 32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.79405411 |
| 33 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.75513607 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74336383 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74205553 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71641768 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68300158 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68173340 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63203224 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60995636 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59793241 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58991846 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58097237 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55628967 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55236528 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54778651 |
| 47 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.53897591 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.52583296 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.52144008 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52131418 |
| 51 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50951212 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.49656989 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49621989 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49217096 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49198934 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46630595 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46154353 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45339117 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45096430 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42369350 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42317861 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40363741 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36733239 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36336154 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35517183 |
| 66 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.35090883 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.34669881 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33252101 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31269521 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30849846 |
| 71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30140886 |
| 72 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25109623 |
| 73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22672674 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21833094 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21275314 |
| 76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21120743 |
| 77 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.18295681 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17905535 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17792557 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17287100 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16867986 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16833361 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16308990 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16298047 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15780058 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15616642 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14954553 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14754155 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13777312 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12908014 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11908888 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11582312 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10826051 |
| 94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10327900 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09872700 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08959428 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 1.08907459 |
| 98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08584474 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07427426 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07118755 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06835576 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06569486 |
| 103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06568830 |
| 104 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06365738 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05906964 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04892946 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04435635 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04367845 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04258525 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02868568 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02767316 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02747590 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02394971 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02269032 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02216959 |
| 116 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.01870592 |
| 117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01742904 |
| 118 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99863877 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99533525 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98931921 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98107365 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97988571 |
| 123 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93366530 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93018924 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93018307 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92021105 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91837212 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91619514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.56481034 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.47550231 |
| 3 | MP0005451_abnormal_body_composition | 3.17620213 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.11208083 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.97992340 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.72255308 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.58159713 |
| 8 | MP0004510_myositis | 2.55840973 |
| 9 | MP0000685_abnormal_immune_system | 2.55473589 |
| 10 | MP0008260_abnormal_autophagy | 2.48410622 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.35355441 |
| 12 | MP0001790_abnormal_immune_system | 2.33235836 |
| 13 | MP0005387_immune_system_phenotype | 2.33235836 |
| 14 | MP0003436_decreased_susceptibility_to | 2.24098772 |
| 15 | MP0001800_abnormal_humoral_immune | 2.13890063 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.07795655 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.96515181 |
| 18 | MP0002909_abnormal_adrenal_gland | 1.96126132 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.92122546 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.88324847 |
| 21 | MP0003724_increased_susceptibility_to | 1.79962696 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.78103605 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.76384190 |
| 24 | MP0009840_abnormal_foam_cell | 1.74515884 |
| 25 | MP0000604_amyloidosis | 1.72105004 |
| 26 | MP0009278_abnormal_bone_marrow | 1.70713116 |
| 27 | MP0002090_abnormal_vision | 1.70369015 |
| 28 | MP0005671_abnormal_response_to | 1.70216022 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.68115938 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.65719321 |
| 31 | MP0002398_abnormal_bone_marrow | 1.64922473 |
| 32 | MP0002723_abnormal_immune_serum | 1.62761418 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.60846719 |
| 34 | MP0001819_abnormal_immune_cell | 1.60742190 |
| 35 | MP0009785_altered_susceptibility_to | 1.60729624 |
| 36 | MP0002419_abnormal_innate_immunity | 1.60099477 |
| 37 | MP0002006_tumorigenesis | 1.59613409 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.57751638 |
| 39 | MP0005025_abnormal_response_to | 1.51004231 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.50244521 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.48640265 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.48410108 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.47223005 |
| 44 | MP0004947_skin_inflammation | 1.45817521 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.43033442 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.42145907 |
| 47 | MP0004130_abnormal_muscle_cell | 1.40682781 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.40461444 |
| 49 | MP0000716_abnormal_immune_system | 1.39818676 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.38997721 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.38166133 |
| 52 | MP0001849_ear_inflammation | 1.34824179 |
| 53 | MP0003075_altered_response_to | 1.31965112 |
| 54 | MP0006082_CNS_inflammation | 1.30883275 |
| 55 | MP0004858_abnormal_nervous_system | 1.30597224 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.30258444 |
| 57 | MP0010307_abnormal_tumor_latency | 1.29879877 |
| 58 | MP0003329_amyloid_beta_deposits | 1.29533524 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25619152 |
| 60 | MP0002822_catalepsy | 1.24749810 |
| 61 | MP0003045_fibrosis | 1.23765121 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.22997203 |
| 63 | MP0003091_abnormal_cell_migration | 1.22227772 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.21210320 |
| 65 | MP0002429_abnormal_blood_cell | 1.16662714 |
| 66 | MP0002722_abnormal_immune_system | 1.14823518 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.14309647 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.12294186 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.10940887 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.10608319 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.07347259 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.06956016 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.06589575 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.06440085 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.06217510 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.06217510 |
| 77 | MP0004084_abnormal_cardiac_muscle | 1.04758788 |
| 78 | MP0002064_seizures | 1.04758701 |
| 79 | MP0005166_decreased_susceptibility_to | 1.04470653 |
| 80 | MP0008569_lethality_at_weaning | 1.02486080 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 1.01971634 |
| 82 | MP0004811_abnormal_neuron_physiology | 1.01680470 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.01140746 |
| 84 | MP0003690_abnormal_glial_cell | 0.99674199 |
| 85 | MP0001915_intracranial_hemorrhage | 0.99222715 |
| 86 | MP0001730_embryonic_growth_arrest | 0.98830620 |
| 87 | MP0000371_diluted_coat_color | 0.98604365 |
| 88 | MP0002009_preneoplasia | 0.97156439 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.96572251 |
| 90 | MP0003828_pulmonary_edema | 0.95521507 |
| 91 | MP0000858_altered_metastatic_potential | 0.95291736 |
| 92 | MP0005310_abnormal_salivary_gland | 0.95157211 |
| 93 | MP0003448_altered_tumor_morphology | 0.94324383 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.94140201 |
| 95 | MP0005023_abnormal_wound_healing | 0.94004042 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.92174286 |
| 97 | MP0000609_abnormal_liver_physiology | 0.91858905 |
| 98 | MP0001851_eye_inflammation | 0.91536000 |
| 99 | MP0008874_decreased_physiological_sensi | 0.90704322 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.90336736 |
| 101 | MP0010329_abnormal_lipoprotein_level | 0.89567104 |
| 102 | MP0000350_abnormal_cell_proliferation | 0.89156613 |
| 103 | MP0008469_abnormal_protein_level | 0.88255972 |
| 104 | MP0009046_muscle_twitch | 0.88029345 |
| 105 | MP0002405_respiratory_system_inflammati | 0.87223638 |
| 106 | MP0003866_abnormal_defecation | 0.87071484 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.86773499 |
| 108 | MP0000733_abnormal_muscle_development | 0.86205791 |
| 109 | MP0003633_abnormal_nervous_system | 0.85629041 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.84354097 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.84110987 |
| 112 | MP0001853_heart_inflammation | 0.83174153 |
| 113 | MP0009745_abnormal_behavioral_response | 0.82963892 |
| 114 | MP0000751_myopathy | 0.81868095 |
| 115 | MP0008057_abnormal_DNA_replication | 0.80794086 |
| 116 | MP0001873_stomach_inflammation | 0.80012959 |
| 117 | MP0000490_abnormal_crypts_of | 0.79354329 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.78843004 |
| 119 | MP0000747_muscle_weakness | 0.78216898 |
| 120 | MP0005409_darkened_coat_color | 0.77635088 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.77110596 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.77070043 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76770733 |
| 124 | MP0003077_abnormal_cell_cycle | 0.75951824 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.75715946 |
| 126 | MP0000313_abnormal_cell_death | 0.75664077 |
| 127 | MP0009764_decreased_sensitivity_to | 0.73650467 |
| 128 | MP0001502_abnormal_circadian_rhythm | 0.70518016 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.69684177 |
| 130 | MP0005621_abnormal_cell_physiology | 0.68975577 |
| 131 | MP0002396_abnormal_hematopoietic_system | 0.67030866 |
| 132 | MP0000358_abnormal_cell_content/ | 0.66501310 |
| 133 | MP0001501_abnormal_sleep_pattern | 0.66393341 |
| 134 | MP0004233_abnormal_muscle_weight | 0.65793361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Central scotoma (HP:0000603) | 3.60600205 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58335318 |
| 3 | Hyperacusis (HP:0010780) | 3.00518314 |
| 4 | Fatigue (HP:0012378) | 2.96142923 |
| 5 | Visual hallucinations (HP:0002367) | 2.90175561 |
| 6 | Recurrent viral infections (HP:0004429) | 2.88607501 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87040821 |
| 8 | Peritonitis (HP:0002586) | 2.80271646 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 2.79716470 |
| 10 | Hand muscle atrophy (HP:0009130) | 2.74468140 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.73032335 |
| 12 | Gastrointestinal stroma tumor (HP:0100723) | 2.71624937 |
| 13 | Colitis (HP:0002583) | 2.69996549 |
| 14 | Chronic otitis media (HP:0000389) | 2.66657127 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.62561836 |
| 16 | Papilledema (HP:0001085) | 2.58766297 |
| 17 | Distal upper limb amyotrophy (HP:0007149) | 2.51173336 |
| 18 | Upper limb amyotrophy (HP:0009129) | 2.51173336 |
| 19 | Interstitial pulmonary disease (HP:0006530) | 2.46616455 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 2.45319113 |
| 21 | Scotoma (HP:0000575) | 2.44730155 |
| 22 | Polycythemia (HP:0001901) | 2.41478198 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.40798866 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.39024297 |
| 25 | Insomnia (HP:0100785) | 2.35864650 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35702007 |
| 27 | Increased connective tissue (HP:0009025) | 2.34895323 |
| 28 | Hemiplegia (HP:0002301) | 2.32983339 |
| 29 | Cerebral aneurysm (HP:0004944) | 2.32092591 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.31459574 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.30526360 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29932715 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 2.28331970 |
| 34 | Increased IgE level (HP:0003212) | 2.26621459 |
| 35 | Cellulitis (HP:0100658) | 2.25850204 |
| 36 | Protrusio acetabuli (HP:0003179) | 2.25390666 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.23808773 |
| 38 | Dysmetric saccades (HP:0000641) | 2.23448876 |
| 39 | Cholecystitis (HP:0001082) | 2.22954730 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.22954730 |
| 41 | Pointed chin (HP:0000307) | 2.19849564 |
| 42 | Frequent falls (HP:0002359) | 2.18610141 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.18318883 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.16335261 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.16181443 |
| 46 | Orchitis (HP:0100796) | 2.16064856 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.15349460 |
| 48 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15007815 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.14916532 |
| 50 | Depression (HP:0000716) | 2.12887588 |
| 51 | Global brain atrophy (HP:0002283) | 2.09428180 |
| 52 | Nasal polyposis (HP:0100582) | 2.08181900 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.07417737 |
| 54 | Mitral stenosis (HP:0001718) | 2.07369803 |
| 55 | Striae distensae (HP:0001065) | 2.07072329 |
| 56 | Myokymia (HP:0002411) | 2.05964311 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.03149737 |
| 58 | Macroorchidism (HP:0000053) | 2.01893072 |
| 59 | Elfin facies (HP:0004428) | 2.01747641 |
| 60 | Emphysema (HP:0002097) | 2.00760923 |
| 61 | Meningitis (HP:0001287) | 2.00274829 |
| 62 | Inflammation of the large intestine (HP:0002037) | 1.99969282 |
| 63 | Flat acetabular roof (HP:0003180) | 1.99692220 |
| 64 | Thin bony cortex (HP:0002753) | 1.99392427 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99093802 |
| 66 | Broad face (HP:0000283) | 1.98721613 |
| 67 | Deep palmar crease (HP:0006191) | 1.98637137 |
| 68 | Abnormality of the periventricular white matter (HP:0002518) | 1.97071226 |
| 69 | Slow saccadic eye movements (HP:0000514) | 1.96929170 |
| 70 | Optic neuritis (HP:0100653) | 1.95795960 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 1.95795960 |
| 72 | T lymphocytopenia (HP:0005403) | 1.95755329 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95118529 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95118529 |
| 75 | Abnormality of T cell number (HP:0011839) | 1.93829107 |
| 76 | Long toe (HP:0010511) | 1.93373514 |
| 77 | Reticulocytosis (HP:0001923) | 1.93032058 |
| 78 | Periodontitis (HP:0000704) | 1.93022163 |
| 79 | Abnormality of the fingertips (HP:0001211) | 1.92486775 |
| 80 | Verrucae (HP:0200043) | 1.92345524 |
| 81 | Papilloma (HP:0012740) | 1.92345524 |
| 82 | Vasculitis (HP:0002633) | 1.92067824 |
| 83 | Postural instability (HP:0002172) | 1.91122156 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 1.90788372 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 1.90673690 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89019194 |
| 87 | Pelvic girdle muscle weakness (HP:0003749) | 1.87627088 |
| 88 | Metaphyseal cupping (HP:0003021) | 1.87058430 |
| 89 | Resting tremor (HP:0002322) | 1.86598835 |
| 90 | Deep venous thrombosis (HP:0002625) | 1.86099310 |
| 91 | Spontaneous hematomas (HP:0007420) | 1.84725879 |
| 92 | Subacute progressive viral hepatitis (HP:0006572) | 1.84361681 |
| 93 | Loss of speech (HP:0002371) | 1.84022161 |
| 94 | Disproportionate tall stature (HP:0001519) | 1.83551260 |
| 95 | Asymmetry of the thorax (HP:0001555) | 1.82112029 |
| 96 | Ankyloglossia (HP:0010296) | 1.82093011 |
| 97 | Abnormality of the peritoneum (HP:0002585) | 1.81563801 |
| 98 | Hypertensive crisis (HP:0100735) | 1.80656475 |
| 99 | Generalized hyperpigmentation (HP:0007440) | 1.80086291 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 1.79931377 |
| 101 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79338385 |
| 102 | Obstructive lung disease (HP:0006536) | 1.79338385 |
| 103 | Impaired smooth pursuit (HP:0007772) | 1.78914492 |
| 104 | Hemorrhage of the eye (HP:0011885) | 1.78108575 |
| 105 | Myositis (HP:0100614) | 1.77456608 |
| 106 | Aortic aneurysm (HP:0004942) | 1.76882482 |
| 107 | Neuronal loss in central nervous system (HP:0002529) | 1.76800125 |
| 108 | Premature rupture of membranes (HP:0001788) | 1.75252172 |
| 109 | Recurrent skin infections (HP:0001581) | 1.74689381 |
| 110 | Aneurysm (HP:0002617) | 1.74152899 |
| 111 | Osteomyelitis (HP:0002754) | 1.74116525 |
| 112 | Myocardial infarction (HP:0001658) | 1.74046813 |
| 113 | Arterial thrombosis (HP:0004420) | 1.73428491 |
| 114 | Long palpebral fissure (HP:0000637) | 1.73358151 |
| 115 | Abnormality of the thoracic spine (HP:0100711) | 1.73098771 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72930470 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72930470 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72930470 |
| 119 | Chest pain (HP:0100749) | 1.72856044 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.72764708 |
| 121 | Hypercortisolism (HP:0001578) | 1.72384435 |
| 122 | Persistence of primary teeth (HP:0006335) | 1.72256809 |
| 123 | Abnormality of oral frenula (HP:0000190) | 1.72201539 |
| 124 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71922106 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71677484 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.71677484 |
| 127 | Abnormality of T cells (HP:0002843) | 1.70986526 |
| 128 | IgA deficiency (HP:0002720) | 1.70252463 |
| 129 | Renovascular hypertension (HP:0100817) | 1.69928365 |
| 130 | Obstructive sleep apnea (HP:0002870) | 1.68250266 |
| 131 | Syringomyelia (HP:0003396) | 1.67719180 |
| 132 | Spinal cord lesions (HP:0100561) | 1.67719180 |
| 133 | Dilatation of the ascending aorta (HP:0005111) | 1.67479893 |
| 134 | Dysostosis multiplex (HP:0000943) | 1.67148714 |
| 135 | Viral hepatitis (HP:0006562) | 1.67011233 |
| 136 | Gingivitis (HP:0000230) | 1.66316891 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.65531794 |
| 138 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64972842 |
| 139 | Panhypogammaglobulinemia (HP:0003139) | 1.64229063 |
| 140 | Tetraplegia (HP:0002445) | 1.63766303 |
| 141 | Polygenic inheritance (HP:0010982) | 1.63497246 |
| 142 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.63323863 |
| 143 | Hematochezia (HP:0002573) | 1.63293284 |
| 144 | Ankle clonus (HP:0011448) | 1.63059237 |
| 145 | Hepatitis (HP:0012115) | 1.62829856 |
| 146 | Generalized tonic-clonic seizures (HP:0002069) | 1.62680689 |
| 147 | Focal seizures (HP:0007359) | 1.62382865 |
| 148 | Posterior subcapsular cataract (HP:0007787) | 1.61339415 |
| 149 | Lymphopenia (HP:0001888) | 1.61119717 |
| 150 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.60720491 |
| 151 | Dislocated radial head (HP:0003083) | 1.58477707 |
| 152 | Progressive external ophthalmoplegia (HP:0000590) | 1.57421741 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.55259669 |
| 154 | Peripheral hypomyelination (HP:0007182) | 1.54970821 |
| 155 | Ulnar bowing (HP:0003031) | 1.54801885 |
| 156 | Restrictive lung disease (HP:0002091) | 1.54313966 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.54300366 |
| 158 | Neurofibrillary tangles (HP:0002185) | 1.52857171 |
| 159 | Personality changes (HP:0000751) | 1.51846436 |
| 160 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.51543467 |
| 161 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.51543467 |
| 162 | Abnormality of glycolipid metabolism (HP:0010969) | 1.51543467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.09571788 |
| 2 | PRPF4B | 4.00794048 |
| 3 | MAP3K13 | 3.17023895 |
| 4 | MAP3K9 | 3.16893917 |
| 5 | PKN2 | 2.76529636 |
| 6 | SMG1 | 2.73140803 |
| 7 | ICK | 2.54315415 |
| 8 | TYK2 | 2.53869394 |
| 9 | MAP4K1 | 2.37791266 |
| 10 | JAK1 | 2.34726433 |
| 11 | IRAK3 | 2.11424344 |
| 12 | RIPK1 | 2.03504276 |
| 13 | KSR2 | 2.01024736 |
| 14 | ERN1 | 1.98009204 |
| 15 | MAP2K3 | 1.96843241 |
| 16 | MAP3K10 | 1.95022481 |
| 17 | FGFR4 | 1.94433559 |
| 18 | RIPK4 | 1.84377571 |
| 19 | JAK3 | 1.76274305 |
| 20 | TBK1 | 1.62031354 |
| 21 | TTN | 1.60313303 |
| 22 | NEK9 | 1.58828470 |
| 23 | ALK | 1.54687617 |
| 24 | EEF2K | 1.53946660 |
| 25 | CAMKK1 | 1.53280646 |
| 26 | SCYL2 | 1.51527677 |
| 27 | SIK2 | 1.49910390 |
| 28 | PTK6 | 1.42896077 |
| 29 | IRAK4 | 1.41113112 |
| 30 | TAOK2 | 1.28683156 |
| 31 | JAK2 | 1.28490259 |
| 32 | SIK1 | 1.26947147 |
| 33 | PRKD3 | 1.26617652 |
| 34 | NEK1 | 1.26223701 |
| 35 | DAPK2 | 1.24447586 |
| 36 | PAK6 | 1.24444788 |
| 37 | FES | 1.23468257 |
| 38 | LMTK2 | 1.19755187 |
| 39 | PRKCH | 1.19733423 |
| 40 | NTRK3 | 1.13913772 |
| 41 | SGK3 | 1.12875302 |
| 42 | MAP3K7 | 1.11615740 |
| 43 | MAP3K14 | 1.10222232 |
| 44 | LRRK2 | 1.07642137 |
| 45 | SYK | 1.06766899 |
| 46 | STK38 | 1.01945069 |
| 47 | ZAP70 | 0.99700570 |
| 48 | IKBKE | 0.98936418 |
| 49 | TAOK3 | 0.98912090 |
| 50 | MAPK11 | 0.97985605 |
| 51 | ARAF | 0.97675898 |
| 52 | MAP3K6 | 0.96855279 |
| 53 | MARK2 | 0.96064632 |
| 54 | CAMK1G | 0.93136117 |
| 55 | FGFR3 | 0.92726802 |
| 56 | RET | 0.89931306 |
| 57 | KSR1 | 0.89578776 |
| 58 | PDGFRA | 0.88475724 |
| 59 | DAPK1 | 0.86859465 |
| 60 | CAMK1D | 0.86826719 |
| 61 | HCK | 0.86443825 |
| 62 | CSF1R | 0.85243793 |
| 63 | PDK1 | 0.85152442 |
| 64 | STK10 | 0.84904326 |
| 65 | BMX | 0.84440817 |
| 66 | FLT3 | 0.84022585 |
| 67 | NME2 | 0.83509970 |
| 68 | MAP3K3 | 0.81380533 |
| 69 | NEK2 | 0.80341423 |
| 70 | KIT | 0.79804279 |
| 71 | CSK | 0.77852546 |
| 72 | CDK6 | 0.74916681 |
| 73 | BTK | 0.74475059 |
| 74 | CDC42BPA | 0.74379985 |
| 75 | GRK6 | 0.74321290 |
| 76 | TAOK1 | 0.74136798 |
| 77 | MARK3 | 0.72910487 |
| 78 | TLK1 | 0.70776666 |
| 79 | SIK3 | 0.70363955 |
| 80 | MINK1 | 0.70333170 |
| 81 | MAP3K11 | 0.67211598 |
| 82 | TESK2 | 0.66658678 |
| 83 | MOS | 0.65594584 |
| 84 | MAP3K1 | 0.64680333 |
| 85 | BLK | 0.64567702 |
| 86 | BRSK1 | 0.64337473 |
| 87 | IRAK2 | 0.63730789 |
| 88 | DDR2 | 0.62689503 |
| 89 | STK11 | 0.62452473 |
| 90 | FGR | 0.61657097 |
| 91 | RAF1 | 0.58823736 |
| 92 | HIPK2 | 0.58253499 |
| 93 | NTRK1 | 0.57974208 |
| 94 | MAP3K8 | 0.56199541 |
| 95 | RPS6KA2 | 0.56062870 |
| 96 | MAP3K4 | 0.55338193 |
| 97 | CLK1 | 0.55275551 |
| 98 | RPS6KA4 | 0.55129712 |
| 99 | CDK4 | 0.54860330 |
| 100 | PRKD2 | 0.54465103 |
| 101 | RPS6KB2 | 0.53732217 |
| 102 | PDPK1 | 0.53083367 |
| 103 | EPHA3 | 0.52547356 |
| 104 | PAK4 | 0.51601487 |
| 105 | CDK12 | 0.49305987 |
| 106 | RPS6KC1 | 0.48996082 |
| 107 | RPS6KL1 | 0.48996082 |
| 108 | LCK | 0.48960134 |
| 109 | BRAF | 0.48642268 |
| 110 | SGK2 | 0.48001448 |
| 111 | MTOR | 0.47750451 |
| 112 | MATK | 0.46595745 |
| 113 | MAPK12 | 0.44813959 |
| 114 | NTRK2 | 0.44636561 |
| 115 | LATS2 | 0.44582192 |
| 116 | MELK | 0.44481236 |
| 117 | EPHB1 | 0.44400111 |
| 118 | CDK5 | 0.44226178 |
| 119 | CAMKK2 | 0.43596935 |
| 120 | TYRO3 | 0.43315303 |
| 121 | MAP3K2 | 0.43228061 |
| 122 | ITK | 0.42787384 |
| 123 | PHKG1 | 0.41841957 |
| 124 | PHKG2 | 0.41841957 |
| 125 | MAP3K5 | 0.41520555 |
| 126 | MAPK7 | 0.41107281 |
| 127 | BRD4 | 0.40133614 |
| 128 | TNK2 | 0.39487683 |
| 129 | FYN | 0.38924643 |
| 130 | CDK7 | 0.38757647 |
| 131 | BMPR2 | 0.38406997 |
| 132 | LYN | 0.36366601 |
| 133 | PDGFRB | 0.36057206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26448830 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23700038 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99029178 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95441234 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.82373244 |
| 6 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.70261237 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64000329 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62706269 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52745556 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45370909 |
| 11 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.36354750 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35102770 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34374448 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33905868 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32333659 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28890642 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27986000 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26762085 |
| 19 | Glioma_Homo sapiens_hsa05214 | 1.24959010 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.24516207 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22285846 |
| 22 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18253878 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16436212 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16309198 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.16302863 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.15946482 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14022185 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13679121 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.13144230 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12587935 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.12430928 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11941210 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11406442 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10418446 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10187937 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09770901 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09255498 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08858244 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08249181 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.07038721 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04259035 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04179719 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04132163 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03896954 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.03876065 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.02787134 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02411574 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02147048 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.01987313 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00818990 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99970197 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99876607 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99257273 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98608814 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.98171536 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97909220 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 0.96149840 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95848948 |
| 59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95156762 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94158790 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92808036 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92480755 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91938892 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.91853083 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91795692 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91133997 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90993695 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 0.90871568 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90082777 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.89497876 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89371329 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89013838 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88849908 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88575237 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88276140 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87989818 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87727985 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85857120 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85463738 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.85313667 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83520768 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83083431 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82878366 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82608739 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79122529 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.78657617 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.78427061 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78066398 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76108429 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76099155 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75889806 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75473407 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.74842841 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73764350 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73152139 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72832709 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72363752 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72279897 |
| 99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71629331 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.71090800 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70497520 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69829288 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69535745 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69317872 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69150119 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68573281 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68324096 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.68270955 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.68213075 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67854249 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.66459718 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65522370 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.64623765 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64478451 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62924321 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62889399 |
| 117 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61435540 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60879151 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60616818 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.59308383 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.59191884 |
| 122 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58660851 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58521968 |
| 124 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57783232 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56958825 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56456384 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.56146788 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55762850 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.55726824 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55562696 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55020549 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54760316 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54670666 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.54615134 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53196586 |
| 136 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52731580 |

